Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcript
Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.1.
March 21st, 2024 - News Transcripts
November 12th, 2023 - News Transcripts
August 12th, 2023 - News Transcripts
May 16th, 2023 - News Transcripts
March 18th, 2023 - News Transcripts
Returns since its inception in May 2014 (through Feb 16th, 2024)